KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Times Interest Earned (2018 - 2025)

TherapeuticsMD (TXMD) has disclosed Times Interest Earned for 12 consecutive years, with -$287.33 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned rose 23.99% year-over-year to -$287.33, compared with a TTM value of -$303.29 through Sep 2025, up 86.37%, and an annual FY2021 reading of -$2.42, up 55.58% over the prior year.
  • Times Interest Earned was -$287.33 for Q3 2025 at TherapeuticsMD, up from -$347.5 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $3.27 in Q4 2021 and bottomed at -$435.5 in Q1 2025.
  • Average Times Interest Earned over 5 years is -$138.0, with a median of -$54.14 recorded in 2023.
  • The sharpest move saw Times Interest Earned soared 172.01% in 2021, then crashed 4200.62% in 2023.
  • Year by year, Times Interest Earned stood at $3.27 in 2021, then tumbled by 137.89% to -$1.24 in 2022, then crashed by 7047.55% to -$88.65 in 2023, then tumbled by 326.4% to -$378.0 in 2024, then rose by 23.99% to -$287.33 in 2025.
  • Business Quant data shows Times Interest Earned for TXMD at -$287.33 in Q3 2025, -$347.5 in Q2 2025, and -$435.5 in Q1 2025.